Protalix BioTherapeutics
PLX
#8915
Rank
NZ$0.24 B
Marketcap
NZ$2.99
Share price
-1.14%
Change (1 day)
3.46%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : NZ$49.47 Million

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are NZ$49.47 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$53.55 M-33.41%
2023-12-31NZ$80.43 M-23.12%
2022-12-31NZ$0.10 B-10.34%
2021-12-31NZ$0.11 B-11.35%
2020-12-31NZ$0.13 B-23.39%
2019-12-31NZ$0.17 B1.09%
2018-12-31NZ$0.16 B18.73%
2017-12-31NZ$0.14 B7.55%
2016-12-31NZ$0.13 B5.47%
2015-12-31NZ$0.12 B-26.18%
2014-12-31NZ$0.17 B0.16%
2013-12-31NZ$0.17 B71.08%
2012-12-31NZ$99.78 M-0.01%
2011-12-31NZ$99.79 M1.23%
2010-12-31NZ$98.57 M-13.51%
2009-12-31NZ$0.11 B923.3%
2008-12-31NZ$11.13 M91.65%
2007-12-31NZ$5.81 M51.43%
2006-12-31NZ$3.83 M132.16%
2005-12-31NZ$1.65 M1561.53%
2004-12-31NZ$0.09 M-17.94%
2003-12-31NZ$0.12 M-19.75%
2002-12-31NZ$0.15 M-18.81%
2001-12-31NZ$0.18 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amicus Therapeutics
FOLD
NZ$1.10 B 2,133.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$2.18 B 4,315.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.16 B 404,458.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.43 B 113,960.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel